<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Effect of Evolving Strategies in the Surgical Management of Organ-Confined Prostate Cancer: Comparison of Data from 2005 to 2014 in a Multicenter Setting</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-01-04">January 4, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Margit</forename><forename type="middle">Pohle</forename><surname>Ahmed</surname></persName>
							<email>margit.pohle@gmail.com</email>
						</author>
						<author>
							<persName><forename type="first">Magheli</forename><forename type="middle">Tom</forename><surname>Fischer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kempkensteffen</forename><surname>Carsten</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jonas</forename><surname>Busch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cash</forename><surname>Hannes</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kurt</forename><forename type="middle">Stefan</forename><surname>Miller</surname></persName>
						</author>
						<author>
							<persName><surname>Hinz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Pohle</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Á</forename><forename type="middle">H</forename><surname>Cash</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Á</forename><forename type="middle">K</forename><surname>Miller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Magheli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Á</forename><forename type="middle">S</forename><surname>Hinz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Fischer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Kempkensteffen</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Charite ´Universita ¨tsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Urologische Klinik und Hochschulambulanz</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Vivantes Klinikum Am Urban</orgName>
								<orgName type="institution" key="instit2">Klinik fu ¨r Urologie</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Vivantes Klinikum im Friedrichshain</orgName>
								<orgName type="institution" key="instit2">Klinik fu ¨r Urologie</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Franziskus-Krankenhaus Berlin</orgName>
								<orgName type="institution" key="instit2">Klinik fu ¨r Urologie</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The Effect of Evolving Strategies in the Surgical Management of Organ-Confined Prostate Cancer: Comparison of Data from 2005 to 2014 in a Multicenter Setting</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-01-04">January 4, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">CE4B95B690185FD4D81E07C6C2338CC4</idno>
					<idno type="DOI">10.1007/s12325-016-0469-4</idno>
					<note type="submission">Received: November 13, 2016 /</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Gleason</term>
					<term>Prostate cancer</term>
					<term>Radical prostatectomy</term>
					<term>Robot-assisted RP</term>
					<term>Surgical techniques</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Introduction: The objective of this study was to evaluate changes of patient characteristics and surgical techniques in radical prostatectomy in Germany within the last decade.</s><s>Methods: Data from 44 German prostate cancer centers were included in the study.</s><s>Patients' characteristics (age, initial PSA value), surgical techniques (open vs. minimally invasive approaches), perioperative parameters (operating time, rate of nerve-sparing (NS) radical prostatectomies (RPs), hospitalization time, catheter indwelling time, surgical margin status, number of dissected lymph nodes (LN)), and pathological findings (tumor stage, Gleason score) were analyzed.</s><s>Results: Data from 11,675 patients who underwent RP between 2005 and 2014 were analyzed.</s><s>The rate of open RP approaches decreased by 1.7% (p = 0.0164), the rate of minimally invasive approaches increased by 1.8% (p = 0.0164).</s><s>Robot-assisted RPs (RARP) increased by 4.6% (p\0.0001).</s><s>The number of NS procedures and pelvic lymphadenectomy (LA) increased by 4.5% (p\0.0001) and 4.7% (p\0.0001),</s><s>respectively.</s><s>Catheter indwelling time and hospitalization time decreased by 1 day (p\0.0001).</s><s>No change in the rate of positive surgical margins (p = 0.5061) and the ratio of positive lymph nodes removed (p = 0.4628) was observed.</s><s>The number of Gleason B6 tumors decreased significantly (p\0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>The number of RARP has significantly increased over the past decade and there is a trend towards surgeries on more advanced tumors with higher yields of lymph nodes dissected.</s><s>At the same time, the rate of</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Prostate cancer is one of the most common malignancies in men with more than 1 million new cases being diagnosed worldwide every year <ref type="bibr" target="#b0">[1]</ref>.</s><s>Despite a 5-year relative survival rate of 99.7% for all pathological stages, prostate cancer remains the second leading cause of cancer deaths in men <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s></p><p><s>With the introduction of prostate-specific antigen (PSA)-based prostate cancer screening in the early 1990s, the annual number of radical prostatectomies (RPs) performed in Germany constantly increased until 2007 (source: Federal Statistical Office in Germany).</s><s>The relatively new concept of active surveillance (AS) for low-risk prostate cancer and the introduction of several alternative treatment options in addition to modern radiation therapy have led to a decrease of RP numbers performed in Germany from 28,374 in 2006 to 21,850 in 2013 <ref type="bibr" target="#b3">[4]</ref>.</s><s>This translates into a decline of approximately 930 RPs per year throughout all prostate cancer centers in Germany and does not necessarily reflect a ''paradigm shift'' towards active surveillance as stated in the literature earlier <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>Today, a patient's individual decision between surgery or alternative approaches is not just based on relatively objective clinical parameters; instead, individual factors such as family considerations, social environment, social status, and factors like comorbidities, patient-consultant relationship, and logistic factors, such as accessibility to hospitals and to the latest surgical techniques, are gaining more and more importance <ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>While the number of RP procedures has decreased over the last decade, the technological progress made in the performance of RP procedures has increased especially since the introduction of the robot-assisted radical prostatectomy (RARP) in 2000 <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>In the USA, RARP already represents the most frequently used surgical approach for treatment of localized prostate cancer.</s><s>Current data suggests that in 2008, 80% of RPs in the USA were already robot-assisted and the numbers are increasing <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>In comparison, the proportion of robot-assisted prostatectomies in Germany was 25.2% in 2013 <ref type="bibr" target="#b3">[4]</ref>.</s></p><p><s>Data from the literature and from the Federal Statistical Office in Germany suggest a trend towards an increase of minimally invasive RP procedures performed in Germany over recent years; however, no distinction was made between conventional and robot-assisted laparoscopy <ref type="bibr" target="#b9">[10]</ref>.</s><s>The mean age at the time of surgery of men operated on between 2005 and 2009 was 65.0 years, while the mean age of patients operated on in the second era was 65.7 years (median 66.0 vs. 66.7,</s><s>p\0.0001).</s><s>There was no statistically significant difference in the mean initial PSA values between both eras.</s></p><p><s>The ratio of open RPs has decreased significantly by 1.7% (81.9% vs. 80.2%, p = 0.0164) in the analyzed time period mainly because of a decrease in perineal RPs by 1.2% (7.9% vs. 6.7%, p = 0.0153).</s><s>Minimally invasive procedures increased by 1.8% (18.0% vs. 19.8%,</s><s>p = 0.0164) because of an increase of RARPs by 4.6% (0.02% vs. 4.6%, p\0.0001).</s><s>The classic transperitoneal laparoscopic approach (LRPE) decreased significantly (12.9% vs. 10.3%, p\0.0001).</s><s>No difference was found in the percentage of endoscopic extraperitoneal approaches (EERPE) (p = 0.6484) (Table <ref type="table" target="#tab_2">1</ref>, Fig. <ref type="figure" target="#fig_0">1</ref>).</s></p><p><s>The median operation time of RP procedures was 9 mins longer in the era between 2010 and 2014 than it was between 2005 and 2009 (144 vs. 153 min, p\0.0001).</s><s>In 2010-2014 the rate of nerve-sparing techniques was significantly more utilized compared to 2005-2009 (58.7 vs. 63.2%;</s><s>p\0.0001).</s><s>The median hospitalization time decreased by 1 day (9 vs. 8 days, p\0.0001), as did the catheter indwelling time (9.9 vs. 8.9 days, p\0.0001).</s><s>There was no difference observed between the two eras concerning the surgical margin status (p = 0.5061).</s><s>The mean number of dissected lymph nodes increased from 6.9 to 8.9 (p\0.0001), while the percentage of positive nodes remained unchanged (4.0 vs. 3.1, p = 0.4628).</s><s>Furthermore, there was a significant increase in the rate of pelvic lymphadenectomies performed between 2005 and 2014 (69.7% vs. 74.4%,</s><s>p\0.0001) (Table <ref type="table" target="#tab_3">2</ref>).</s></p><p><s>Between  <ref type="table" target="#tab_5">4</ref>, Fig. <ref type="figure">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Over recent years there has been a significant change in the management of localized prostate cancer.</s><s>As a result of recommendations against PSA testing and screening there has been a decline in RPs as well as pelvic lymph node dissection (PLND) and high dose rate (HDR) brachytherapy over recent years <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s></p><p><s>Furthermore, more and more patients with low-risk tumors are included in active surveillance programs; patients with locally advanced disease or lymph node metastases are treated in multimodal concepts with surgery and consecutive radiation therapy.</s><s>At the same time, the implementation of robot-assisted surgery has led to a broader availability of minimally invasive procedures for the    over the last few years, Germany is still at another level compared to the where currently 70-85% of all RPs are performed with a robot-assisted approach <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>.</s></p><p><s>The analysis of perioperative parameters in this study showed an increase in the operation time by 9 mins (144 vs. 153 min, p\0.0001), an increase in nerve-sparing procedures by 4.5% (p\0.0001), a shorter hospitalization time (9 vs. 8 days, p = 0.0001), and a shorter catheter-indwelling time (9.9 vs. 8.9 days, p = 0.0001), over the last 9 years.</s><s>The increase in the operating time could most likely be explained by the increase in the usage of robot-assisted surgery: according to data in the literature, the operation time with RARP is significantly longer compared to the operation time with open surgery (184.4 vs. 128 min) <ref type="bibr" target="#b13">[14]</ref>.</s><s>Furthermore, the more frequent performance of nerve-sparing procedures might have contributed to a longer surgical time.</s></p><p><s>Our data showed an increase in nerve-sparing procedures by 4.5% over study period of 9 years (58.7% vs. 63.2%,</s><s>p\0.0001).</s></p><p><s>This confirms the desire to achieve better functional outcomes after surgery which can be explained by the demographic changes in highly developed countries and better education of patients concerning the preservation of continence and erectile function.</s><s>Unfortunately, we were not able to extract postoperative functional data from the database.</s><s>Therefore we cannot conclude that the higher rate of nerve sparing resulted in a lower rate of erectile dysfunction following RP <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b14">15]</ref>.</s></p><p><s>In patients included in our analysis the median hospitalization time as well as the catheter-indwelling time both significantly decreased by 1 day during the study period of 9 years (9 vs. 8 days, 9.9 vs. 8.9 days, p\0.0001).</s><s>Beside the general aspects of changing healthcare systems and the related economic reasons in hospitals to keep hospital stays for patients as short as possible, these findings can also be explained by the fact that according to data in the literature RARPs not only promise better functional but also better perioperative outcomes, e.g., a shorter hospitalization and catheter indwelling time with RARP compared to open RP <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s>A similar analysis of data from the same database showed that hospitalization time decreased by 2 days between 2005 and 2008 (10 vs. 8 days) <ref type="bibr" target="#b9">[10]</ref>.</s><s>One argument of the advocates of RARP is the reduced length of hospitalization and therefore improved quality of life for the patient <ref type="bibr" target="#b7">[8]</ref>.</s><s>However, there are also other studies that show similar perioperative, oncological, and functional outcomes for laparoscopic RP compared to open and robotic RP if surgeons were high volume surgeons <ref type="bibr" target="#b16">[17]</ref>.</s></p><p><s>In our analysis of patients operated on between 2005 and 2014 we showed a significant increase in the number of lymph node dissections performed during RP (69.7% vs. 74.4%,</s><s>p\0.0001).</s><s>We also demonstrated that there has been a trend to operate on more intermediate-and high-risk tumors (Gleason 7b, 8, 9, and 10) in the more recent era compared to 9 years ago (Table <ref type="table" target="#tab_4">3</ref>).</s><s>These findings of an increase in lymph node dissections and an increase in the surgery of high-risk prostate cancers are closely connected and can be explained by recently published findings which showed that a multimodal approach with RP combined with an extended lymphadenectomy and/or adjuvant radiotherapy can improve mortality up to 10-15%, especially in high-risk patients <ref type="bibr" target="#b17">[18]</ref>.</s></p><p><s>Additionally, the increase in lymph node dissection is one of the main characteristics that may be related to the use of RARP.</s><s><ref type="bibr" target="#b20">[21]</ref>.</s><s>Our analysis did not include data about the number of positive biopsies, the ratio of cancer within this biopsy, or any information about the clinical T stage of these patients, which is essential for clinical decision-making.</s><s>Additionally, before drawing conclusions from the data analyzed in this study one has to take into account the weaknesses of data arising from a multicenter Internet-based database like this.</s><s>As there are typically no study nurses or dedicated clinical staff in the different centers responsible for ensuring a timely and correct documentation of complete data in all patients, the integrity of the different parameters is not always given.</s><s>Thus, one major limitation of the current study is the high percentage of patients with missing data and/or lost to follow-up, which could have resulted in a selection bias.</s><s>Nevertheless, this database is one of the biggest sources of data on RP in Germany and therefore it most likely represents the clinical reality in Germany.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p><s>Our data confirms the trend towards modern laparoscopic surgical techniques.</s><s>In particular, robot-assisted radical prostatectomy is gaining more and more importance across a broad range of prostate cancer centers in Germany.</s><s>Furthermore, we demonstrated a decrease in low-risk prostate cancer patients who underwent RP.</s><s>At the same time more intermediate-and high-risk prostate cancer patients are currently treated surgically.</s><s>Functional outcomes like the preservation of erectile function and continence are gaining more and more importance due to the raising awareness and better education of patients as well as the use of robotic systems.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Changes in the surgical management of prostate cancer: comparison of data from 2005-2009 vs. 2010-2014</s></p></div></figDesc><graphic coords="4,57.38,255.12,221.28,146.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1</head><label>1</label><figDesc><div><p><s>Overview over the changes in surgical techniques over time</s></p></div></figDesc><table><row><cell>RP technique</cell><cell cols="4">Era 2005-2009 Era 2010-2014 Difference p value</cell></row><row><cell>Percentage perineal RP (%)</cell><cell>7.9</cell><cell>6.7</cell><cell>-1.2</cell><cell>0.0153</cell></row><row><cell>Percentage retropubic RP (%)</cell><cell>74.0</cell><cell>73.5</cell><cell>-0.5</cell><cell>0.5037</cell></row><row><cell>Percentage of all open RP (%)</cell><cell>81.9</cell><cell>80.2</cell><cell>-1.7</cell><cell>0.0164</cell></row><row><cell>Percentage of robot-assisted RP (RARP) (%)</cell><cell>0.02</cell><cell>4.6</cell><cell>4.6</cell><cell>0.0001</cell></row><row><cell>Percentage of endoscopic extraperitoneal RP (EERPE) (%)</cell><cell>5.1</cell><cell>4.9</cell><cell>-0.2</cell><cell>0.6484</cell></row><row><cell cols="2">Percentage of laparoscopic transperitoneal RP (LRPE) (%) 12.9</cell><cell>10.3</cell><cell>-2.6</cell><cell>0.0001</cell></row><row><cell>Percentage of all minimally invasive RP (%)</cell><cell>18.0</cell><cell>19.8</cell><cell>1.8</cell><cell>0.0164</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p><s>Comparison of perioperative parameters over time</s></p></div></figDesc><table><row><cell>Perioperative parameter</cell><cell>Era 2005-2009</cell><cell>Era 2010-2014</cell><cell>Difference</cell><cell>p value</cell></row><row><cell>Median operating time (min)</cell><cell>144.0</cell><cell>153.0</cell><cell>9.0</cell><cell>0.0001</cell></row><row><cell>Rate of nerve-sparing operations (%)</cell><cell>58.7</cell><cell>63.2</cell><cell>4.5</cell><cell>0.0001</cell></row><row><cell>Median hospitalization time (days)</cell><cell>9.0</cell><cell>8.0</cell><cell>-1.0</cell><cell>0.0001</cell></row><row><cell>Median catheter indwelling time (days)</cell><cell>9.9</cell><cell>8.9</cell><cell>-1.0</cell><cell>0.0001</cell></row><row><cell>Positive surgical margin R1 (%)</cell><cell>25.8</cell><cell>25.6</cell><cell>-0.2</cell><cell>0.5061</cell></row><row><cell>Mean number of dissected lymph nodes</cell><cell>6.9</cell><cell>8.9</cell><cell>2.0</cell><cell>0.0001</cell></row><row><cell>% positive lymph nodes</cell><cell>4.0</cell><cell>3.1</cell><cell>-0.9</cell><cell>0.4628</cell></row><row><cell>Rate of pelvic LA (%)</cell><cell>69.7</cell><cell>74.4</cell><cell>4.7</cell><cell>0.0001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3</head><label>3</label><figDesc><div><p><s>Pathologic outcomes: proportion of patients with different pathologic Gleason scores</s></p></div></figDesc><table><row><cell>Pathologic Gleason score</cell><cell>Era 2005-2009</cell><cell>Era 2010-2014</cell><cell>Difference</cell><cell>p value</cell></row><row><cell>Gleason\6 (%)</cell><cell>4.1</cell><cell>1.0</cell><cell>-3.1</cell><cell>0.0001</cell></row><row><cell>Gleason 6 (%)</cell><cell>25.3</cell><cell>19.5</cell><cell>-5.8</cell><cell>0.0001</cell></row><row><cell>Gleason 7(3 ? 4) (%)</cell><cell>41.3</cell><cell>42.3</cell><cell>1.0</cell><cell>0.2875</cell></row><row><cell>Gleason 7(4 ? 3) (%)</cell><cell>16.3</cell><cell>19.7</cell><cell>3.4</cell><cell>0.0001</cell></row><row><cell>Gleason 8 (%)</cell><cell>6.3</cell><cell>6.6</cell><cell>0.3</cell><cell>0.523</cell></row><row><cell>Gleason 9 (%)</cell><cell>6.1</cell><cell>10.2</cell><cell>4.1</cell><cell>0.0001</cell></row><row><cell>Gleason 10 (%)</cell><cell>0.2</cell><cell>0.6</cell><cell>0.4</cell><cell>0.002</cell></row></table><note><p><s>[4]. 2 Changes in the pathologic Gleason scores over time years 2013 and 2014 showed that in 2014, fewer younger men (age 45-75) and older men (age 75-85 and age 90-95) underwent RP compared to in 2013.Interestingly, this data introduction of RARP implemented in more and more centers led to a decrease of open RPs during the study period of 9 years.Data fromthe literature shows that while 1.5% of all hospitals in Germany performed RPs using a robot in 2006, this rate increased to 13% in 2013[4].</s><s>The increase of RARP in our data was 4.6% over the study period and does not necessarily reflect the reality in German treatment; this discrepancy could be explained by the fact that most of the participating prostate cancer centers did not offer robot-assisted surgery.</s><s>However, the increase of RARP procedures by 4.6% in 44 German centers within 9 years seems to draw a realistic picture when comparing our data with data from the Federal Statistical Office which evaluated the overall number of laparoscopic</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4</head><label>4</label><figDesc><div><p><s>Pathologic outcomes: pathologic tumor stages Changes in the pathological T stage</s></p></div></figDesc><table><row><cell>Pathologic T stage pT2a (%) pT2b (%) pT2c (%) pT3a (%) pT3b (%) pT4 (%) Fig. 3 Adv Ther (2017) 34:576-585</cell><cell>Era 2005-2009 10.7 2.8 54.5 17.1 12.8 1.9</cell><cell>Era 2010-2014 10.3 1.6 52.3 18.5 15.8 0.9</cell><cell>Difference -0.4 -1.2 -2.2 1.4 3.0 -1.0</cell><cell>p value 0.6226 0.0001 0.0321 0.0545 0.0001 0.0001</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Adv Ther (2017) 34:576-585</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Compliance with Ethics Guidelines.</s><s>All procedures followed were in accordance with the ethical standards of the responsible</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Epidemiology of prostate cancer: current status</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="805" to="812" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cancer treatment and survivorship statistics</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Desantis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Mariotto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="252" to="271" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Active surveillance and surgery in localized prostate cancer</title>
		<author>
			<persName><forename type="first">O</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Minerva Urol Nefrol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="175" to="187" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Robots drive the German radical prostatectomy market: a total population analysis from</title>
		<author>
			<persName><forename type="first">C</forename><surname>Groeben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baunacke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Wirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prostate Cancer Prostat Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="412" to="416" />
			<date type="published" when="2006">2016. 2006. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Active surveillance or active treatment in localized prostate cancer?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Weissbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Altwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dtsch Arztebl Int</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="371" to="376" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Interdisciplinary decision making in prostate cancer therapy-5-years&apos; time trends at the interdisciplinary prostate cancer center (IPC) of the Charite Berlin</title>
		<author>
			<persName><forename type="first">D</forename><surname>Baumunk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reunkoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kushner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">83</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Robot-assisted radical prostatectomy-review of the literature concerning oncological and functional outcome of patients</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gilfrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brookman-May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lebentrau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aktuelle Urol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="486" to="477" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Regional cost variations of robot-assisted radical prostatectomy compared with open radical prostatectomy</title>
		<author>
			<persName><forename type="first">I</forename><surname>Faiena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">Y</forename><surname>Dombrovskiy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Modi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Genitourin Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="447" to="452" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Robot-assisted radical prostatectomy in prostate cancer</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gandaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Montorsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Karakiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Oncol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2767" to="2773" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Time trends in prostate cancer surgery: data from an Internet-based multicentre database</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schostak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baumunk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jagota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="355" to="359" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Australian patterns of prostate cancer care: are they evolving?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Papa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lawrentschuk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prostate Int</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="20" to="24" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Moyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Uspst</forename><surname>Force</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="120" to="134" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade</title>
		<author>
			<persName><forename type="first">L</forename><surname>Budaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Spethmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Isbarn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Da Vinci and open radical prostatectomy: comparison of clinical outcomes and analysis of insurance costs</title>
		<author>
			<persName><forename type="first">C</forename><surname>Niklas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Berg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Urol Int</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="287" to="294" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Robotic-assisted radical prostatectomy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neisius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Roos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Thuroff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Urol A</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="178" to="182" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Hospitalization costs for radical prostatectomy attributable to robotic surgery</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Karnes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="11" to="16" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Australian laparoscopic non robotic radical prostatectomy experience-analysis of 2943 cases (Usanz supplement)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Louie-Johnsun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Handmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Calopedos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="43" to="48" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Multimodal therapy of locally advanced prostate cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Heidenreich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bohmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Urologe A</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="333" to="344" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: differences between open and robot-assisted radical prostatectomy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schiffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Leyh-Bannurah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Surg Oncol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1547" to="1553" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Nezolosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Dinh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Muralidhar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Urol Oncol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">57</biblScope>
			<biblScope unit="page" from="e15" to="22" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian prostate cancer registry</title>
		<author>
			<persName><forename type="first">M</forename><surname>Weerakoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Papa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lawrentschuk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="50" to="56" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
